Akebia Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $262k | 199k | 1.32 |
| 2024-06-30 | $392k | 384k | 1.02 |
| 2024-03-31 | $777k | 424k | 1.83 |
| 2023-12-31 | $538k | 434k | 1.24 |
| 2023-09-30 | $207k | 182k | 1.14 |
| 2023-06-30 | $136k | 148k | 0.92 |
| 2023-03-31 | $63k | 113k | 0.56 |
| 2022-12-31 | $70k | 122k | 0.58 |
| 2022-06-30 | $226k | 640k | 0.35 |
| 2022-03-31 | $766k | 1.1M | 0.72 |
| 2021-12-31 | $1.6M | 697k | 2.26 |
| 2021-09-30 | $970k | 337k | 2.88 |
| 2021-06-30 | $1.9M | 495k | 3.79 |
| 2021-03-31 | $2.1M | 613k | 3.39 |
| 2020-12-31 | $3.4M | 1.2M | 2.80 |
| 2020-09-30 | $1.6M | 642k | 2.51 |
| 2020-06-30 | $1.5M | 113k | 13.58 |
| 2020-03-31 | $2.1M | 273k | 7.58 |
| 2019-12-31 | $6.0M | 942k | 6.32 |
| 2019-09-30 | $1.4M | 371k | 3.83 |
| 2019-06-30 | $497k | 103k | 4.85 |
| 2019-03-31 | $265k | 32k | 8.16 |
| 2018-12-31 | $8.0M | 1.4M | 5.53 |
| 2018-09-30 | $9.1M | 1.0M | 8.83 |
| 2018-06-30 | $6.5M | 656k | 9.98 |
| 2018-03-31 | $2.3M | 244k | 9.53 |
| 2017-12-31 | $226k | 15k | 14.87 |
| 2017-09-30 | $315k | 16k | 19.69 |
| 2017-06-30 | $294k | 21k | 14.36 |
| 2017-03-31 | $603k | 66k | 9.19 |
| 2016-12-31 | $409k | 39k | 10.41 |
| 2016-06-30 | $193k | 26k | 7.47 |
| 2016-03-31 | $190k | 21k | 9.00 |
| 2015-09-30 | $562k | 64k | 8.80 |
| 2014-03-31 | $361k | 18k | 19.57 |